Posted by & filed under Financial Planning, Growth & Valuation, Market Analysis.

Description: Pershing Square’s Bill Ackman wasn’t able to convince Wall Street once and for all whether embattled drugmaker Valeant Pharmaceuticals can recover from its woes or will continue heading south.

Source: Forbes.com

Date: Oct 30, 2015

Link: http://www.forbes.com/sites/antoinegara/2015/10/30/bill-ackmans-defense-of-valeant-pharmaceuticals-takes-long-view-on-drugmakers-woes/

Questions for discussion:

  • What does the article say about Bill Ackman’s strategic thinking?
  • Do you agree?

Leave a Reply

Your email address will not be published.